Literature DB >> 19525901

Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.

Balazs Hegedus1, Frank W Hughes, Joel R Garbow, Scott Gianino, Debasish Banerjee, Keunyoung Kim, Mark H Ellisman, Milam A Brantley, David H Gutmann.   

Abstract

Individuals with neurofibromatosis type 1 (NF1) are prone to develop optic pathway gliomas that can result in significant visual impairment. To explore the cellular basis for the reduced visual function resulting from optic glioma formation, we used a genetically engineered mouse model of Nf1 optic glioma (Nf1+/-(GFAP)CKO mice). We performed multimodal functional and structural analyses both before and after the appearance of macroscopic tumors. At 6 weeks of age, before obvious glioma formation, Nf1+/-(GFAP)CKO mice had decreased visual-evoked potential amplitudes and increased optic nerve axon calibers. By 3 months of age, Nf1+/-(GFAP)CKO mice exhibited pronounced optic nerve axonopathy and apoptosis of neurons in the retinal ganglion cell layer. Magnetic resonance diffusion tensor imaging showed a progressive increase in radial diffusivity between 6 weeks and 6 months of age in the optic nerve proximal to the tumor indicating ongoing deterioration of axons. These data suggest that optic glioma formation results in early axonal disorganization and damage, which culminates in retinal ganglion cell death. Collectively, this study shows that Nf1+/-(GFAP)CKO mice can provide a useful model for defining mechanisms of visual abnormalities in children with NF1 and lay the foundations for future interventional studies aimed at reducing visual loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19525901      PMCID: PMC2746323          DOI: 10.1097/NEN.0b013e3181a3240b

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  42 in total

1.  Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.

Authors:  L Kornreich; S Blaser; M Schwarz; A Shuper; T H Vishne; I J Cohen; R Faingold; S Michovitz; B Koplewitz; G Horev
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Effects of cultured astroglia on the survival of neonatal rat retinal ganglion cells in vitro.

Authors:  C A McCaffery; T R Raju; M R Bennett
Journal:  Dev Biol       Date:  1984-08       Impact factor: 3.582

3.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

4.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

Authors:  T L Chenevert; L D Stegman; J M Taylor; P L Robertson; H S Greenberg; A Rehemtulla; B D Ross
Journal:  J Natl Cancer Inst       Date:  2000-12-20       Impact factor: 13.506

5.  Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.

Authors:  Feng-Chun Yang; David A Ingram; Shi Chen; Yuan Zhu; Jin Yuan; Xiaohong Li; Xianlin Yang; Scott Knowles; Whitney Horn; Yan Li; Shaobo Zhang; Yanzhu Yang; Saeed T Vakili; Menggang Yu; Dennis Burns; Kent Robertson; Gary Hutchins; Luis F Parada; D Wade Clapp
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

6.  Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.

Authors:  Michaela Livia Bajenaru; Yuan Zhu; Nicolé M Hedrick; Jessica Donahoe; Luis F Parada; David H Gutmann
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

7.  Optic gliomas in children with neurofibromatosis type 1.

Authors:  R Listernick; J Charrow; M J Greenwald; N B Esterly
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

8.  Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.

Authors:  M Livia Bajenaru; M Rosario Hernandez; Arie Perry; Yuan Zhu; Luis F Parada; Joel R Garbow; David H Gutmann
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

9.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus.

Authors:  S Srinivas; T Watanabe; C S Lin; C M William; Y Tanabe; T M Jessell; F Costantini
Journal:  BMC Dev Biol       Date:  2001-03-27       Impact factor: 1.978

10.  A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas.

Authors:  Maria Teresa S Trisciuzzi; Riccardo Riccardi; Marco Piccardi; Giancarlo Iarossi; Luca Buzzonetti; Anna Dickmann; Cesare Colosimo; Antonio Ruggiero; Concezio Di Rocco; Benedetto Falsini
Journal:  Clin Neurophysiol       Date:  2004-01       Impact factor: 3.708

View more
  22 in total

1.  Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.

Authors:  Peter Matthew Kennedy de Blank; Jeffrey Ira Berman; Grant T Liu; Timothy Paul Leslie Roberts; Michael Jay Fisher
Journal:  Neuro Oncol       Date:  2013-05-07       Impact factor: 12.300

2.  NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Authors:  Joseph A Toonen; Corina Anastasaki; Laura J Smithson; Scott M Gianino; Kairong Li; Robert A Kesterson; David H Gutmann
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

Review 3.  Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.

Authors:  Morgan E Freret; David H Gutmann
Journal:  J Neurosci Res       Date:  2018-04-28       Impact factor: 4.164

Review 4.  Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Authors:  Robert Listernick; Rosalie E Ferner; Grant T Liu; David H Gutmann
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

5.  Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.

Authors:  Grant W Simmons; Winnie W Pong; Ryan J Emnett; Crystal R White; Scott M Gianino; Fausto J Rodriguez; David H Gutmann
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

6.  Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.

Authors:  Joseph A Toonen; Yu Ma; David H Gutmann
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

Review 7.  Modeling cognitive dysfunction in neurofibromatosis-1.

Authors:  Kelly A Diggs-Andrews; David H Gutmann
Journal:  Trends Neurosci       Date:  2013-01-08       Impact factor: 13.837

8.  Comparison of multi-shot and single shot echo-planar diffusion tensor techniques for the optic pathway in patients with neurofibromatosis type 1.

Authors:  Chang Y Ho; Rachael Deardorff; Stephen F Kralik; John D West; Yu-Chien Wu; Chie-Schin Shih
Journal:  Neuroradiology       Date:  2019-01-25       Impact factor: 2.804

Review 9.  Pediatric gliomas as neurodevelopmental disorders.

Authors:  Suzanne J Baker; David W Ellison; David H Gutmann
Journal:  Glia       Date:  2015-12-06       Impact factor: 7.452

10.  The impact of coexisting genetic mutations on murine optic glioma biology.

Authors:  Aparna Kaul; Joseph A Toonen; Scott M Gianino; David H Gutmann
Journal:  Neuro Oncol       Date:  2014-09-21       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.